Related Experiment Video
Updated: Nov 6, 2025

08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.3K
Brain Somatic Mutation in Aging and Alzheimer's Disease
Michael B Miller1,2,3,4, Hannah C Reed1,2,5, Christopher A Walsh1,2,4,6,7
1Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts 02115, USA;
Annual Review of Genomics and Human Genetics
|May 12, 2021
Summary
Somatic mutations, genetic changes within cells, accumulate in aging brain neurons. Recent studies explore their role in brain aging and Alzheimer's disease (AD), revealing insights into cellular dysfunction.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Somatic mutations are genetic alterations occurring postzygotically, leading to cellular genetic differences.
- While known cancer drivers, somatic mutations also occur in non-cancerous cells, including the brain.
- Recent technological advances in nucleic acid sequencing have spurred research into their role in aging and neurodegenerative diseases.
Purpose of the Study:
- To review recent concepts, methods, and findings on the role of somatic mutations in brain aging and Alzheimer's disease (AD).
- To highlight the accumulation of somatic mutations in human neurons during aging (genosenium).
- To discuss insights into cellular events driving somatic mutation and dysfunction.
Main Methods:
- Review of recent scientific literature and studies.
- Analysis of technological advancements in nucleic acid sequencing.
- Examination of genome-wide mutation data.
Main Results:
- Somatic mutations accumulate in aging human neurons, a process termed genosenium.
- Studies increasingly examine somatic mutations in Alzheimer's disease (AD), particularly concerning familial AD genes.
- New information on genome-wide mutations provides insights into the cellular basis of somatic mutation and dysfunction.
Conclusions:
- Brain somatic mutations play a significant role in aging and Alzheimer's disease.
- Understanding these mutations is crucial for deciphering cellular dysfunction in neurodegeneration.
- Continued research using advanced sequencing technologies will further elucidate these processes.
Related Concept Videos
Alzheimer's Disease: Overview
958
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
958
Aging
383
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
383
Alzheimer's Disease: Treatment
467
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
467
Amyloid Fibrils
11.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.0K

